Literature DB >> 30454738

Bartter Syndrome and Gitelman Syndrome.

Rosanna Fulchiero1, Patricia Seo-Mayer2.   

Abstract

Bartter and Gitelman syndromes are conditions characterized by renal salt-wasting. Clinical presentations range from severe antenatal disease to asymptomatic with incidental diagnosis. Hypokalemic hypochloremic metabolic alkalosis is the common feature. Bartter variants may be associated with polyuria and weakness. Gitelman syndrome is often subtle, and typically diagnosed later life with incidental hypokalemia and hypomagnesemia. Treatment may involve fluid and electrolyte replenishment, prostaglandin inhibition, and renin-angiotensin-aldosterone system axis disruption. Investigators have identified causative mutations but genotypic-phenotypic correlations are still being characterized. Collaborative registries will allow improved classification schema and development of effective treatments.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bartter syndrome (BS); Failure to thrive; Gitelman syndrome (GS); Hypokalemic hypochloremic metabolic alkalosis; Polyuria; Salt-losing tubulopathy

Mesh:

Year:  2019        PMID: 30454738     DOI: 10.1016/j.pcl.2018.08.010

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  13 in total

1.  A novel homozygous mutation (p.N958K) of SLC12A3 in Gitelman syndrome is associated with endoplasmic reticulum stress.

Authors:  W Tang; X Huang; Y Liu; Q Lv; T Li; Y Song; X Zhang; X Chen; Y Shi
Journal:  J Endocrinol Invest       Date:  2020-07-08       Impact factor: 4.256

2.  METFORMIN-AND GLICLAZIDE-BASED DIABETES TREATMENT EXPERIENCE IN A PATIENT WITH GITELMAN SYNDROME.

Authors:  A Cizmecioglu
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Apr-Jun       Impact factor: 1.104

3.  Clinical and Genetic Characterization of Patients with Bartter and Gitelman Syndrome.

Authors:  Viviana Palazzo; Valentina Raglianti; Samuela Landini; Luigi Cirillo; Carmela Errichiello; Elisa Buti; Rosangela Artuso; Lucia Tiberi; Debora Vergani; Elia Dirupo; Paola Romagnani; Benedetta Mazzinghi; Francesca Becherucci
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

4.  Gitelman syndrome caused by a novel hemiallelic missense mutation in SLC12A3 revealed by 16q12.2q21 microdeletion.

Authors:  Yuki Abe; Toshiyuki Yamamoto; Yukie Izumita; Shinya Tsukano
Journal:  Hum Genome Var       Date:  2020-05-27

5.  Kidney stones and moderate proteinuria as the rare manifestations of Gitelman syndrome.

Authors:  Qi Chen; Xiaoyi Wang; Jingjing Min; Lin Wang; Lijun Mou
Journal:  BMC Nephrol       Date:  2021-01-07       Impact factor: 2.388

Review 6.  Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.

Authors:  Laura Nuñez-Gonzalez; Noa Carrera; Miguel A Garcia-Gonzalez
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

7.  Different roles of the RAAS affect bone metabolism in patients with primary aldosteronism, Gitelman syndrome and Bartter syndrome.

Authors:  Wangna Tang; Yun Chai; Hongwei Jia; Baoping Wang; Tong Liu; Hao Wang; Chenlin Dai
Journal:  BMC Endocr Disord       Date:  2022-02-11       Impact factor: 2.763

8.  Sub-chronic microcystin-LR renal toxicity in rats fed a high fat/high cholesterol diet.

Authors:  Tarana Arman; Katherine D Lynch; Michael Goedken; John D Clarke
Journal:  Chemosphere       Date:  2020-10-27       Impact factor: 7.086

9.  Dehydrated patient without clinically evident cause: A case report.

Authors:  Federica Palladino; Maria Cristina Fedele; Marianna Casertano; Laura Liguori; Tiziana Esposito; Stefano Guarino; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

10.  Viewing Cortical Collecting Duct Function Through Phenotype-guided Single-Tubule Proteomics.

Authors:  Nina Himmerkus; Samuel L Svendsen; Catarina Quintanova; Markus Bleich; Otto Von Schwerdtner; Thomas Benzing; Paul A Welling; Jens Leipziger; Markus M Rinschen
Journal:  Function (Oxf)       Date:  2020-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.